Growth hormone response to baclofen in patients with mania: A pilot study

Psychopharmacology

Volumn 147, Issue 3, 1999, Pages 280-284

  Shiah, I Shin ^a,b   Yatham, Lakshmi N ^a   Lam, Raymond W ^a   Tam, Edwin M ^a   Zis, Athanasios P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Baclofen; Bipolar disorder; GABA; GABA(B) receptor; Growth hormone; Mania

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; GROWTH HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MANIA; NEUROTRANSMISSION; PRIORITY JOURNAL; RATING SCALE; RECEPTOR UPREGULATION;

ACUTE DISEASE; ADULT; AREA UNDER CURVE; BACLOFEN; BIPOLAR DISORDER; FEMALE; GABA AGONISTS; HUMAN GROWTH HORMONE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, GABA-B; TIME FACTORS;

EID: 0033987121     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051168     Document Type: Article

References (32)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, D.C.
2. Ansseau M, von Frenckell R, Cerfontaine J-L, Papart P, Franck G, Timsit-Berthier M, Geenen V, Legros J-L (1987) Neuroendocrine evaluation of catecholaminergic neurotransmission in mania. Psychiatry Res 22:193-206
3. Berrettini WH, Nurnberger JI, Hare TA, Gershon ES (1985) CSF GABA in bipolar affective illness. In: Shagass C, Josiassen R, Bridger W, Weiss K, Stoff D, Simpson G (eds) Proceedings of the World Congress of Biological Psychiatry. Elsevier, Amsterdam, pp 926-928
4. Berrettini WH, Nurnberger JI, Hare TA, Simmons-Alling S, Gershon ES (1986) CSF GABA in euthymic manic-depressive patients and controls. Biol Psychiatry 21:844-846
5. Buki VMV, Goodnick PJ (1998) Catecholamines. In: Goodnick PJ (eds) Mania: Clinical and Research Perspectives. American Psychiatric Press, Washington, D.C., pp 119-134
6. B agonist baclofen in major depressive disorder. Psychoneuroendocrinology 22:129-140
7. Dinan TG, Yatham LN, O'Keane V, Barry S (1991) Blunting of noradrenergic-stimulated growth hormone release in mania. Am J Psychiatry 148:936-938
8. Emrich HM, Zerssen DV, Kissling W, Moller HJ, Windorfer A (1980) Effect of sodium valproate on mania: The GABA-hypothesis of affective disorders. Arch Psychiatr Nervenkr 229:1-16
9. 2-adrenoceptor. Neurochem Int 7:155-163
10. Gamse R, Vaccaro DE, Gamse G, Dipace M, Fox TO, Leeman SE (1980) Release of immunoreactive somatostatin from hypothalamic cell culture: inhibition by γ-aminobutyric acid. Proc Natl Acad Sci USA 77:5552-5556
11. Gerner RH, Hare TA (1981) CSF GABA in normal subjects and patients with depression, schizophrenia, mania and anorexia nervosa. Am J Psychiatry 138:1098-1101
12. Gerner RH, Fairbanks L, Anderson GM, Young JG, Scheinin M, Linnoila M, Hare TA, Shaywitz BA, Cohen DJ (1984) CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. Am J Psychiatry 141:1533-1540
13. Koulu M, Lammintausta R, Dahlstrom S (1979) Stimulatory effect of acute baclofen administration on human growth hormone and prolactin secretion in man. J Clin Endocrinol Metab 48:1038-1040
14. Lloyd KG, Thuret F, Pilc A (1985) Upregulation of γ-aminobutyric acid (GABA)B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J Pharmacol Exp Ther 235:191-199
15. Maggi A, Enna SJ (1980) Regional alterations in rat brain neuro-transmitter systems following chronic lithium treatment. J Neurochem 34:888-892
16. Marchesi C, Chiodera P, De Ferri A, De Risio C, Dasso L, Menozzi P, Volpi R, Coiro V (1991) Reduction of GH response to the GABA-B agonist baclofen in patients with major depression. Psychoneuroendocrinology 16:475-479
17. Monteleone P, Maj M, Iovino M, Steardo L (1990) GABA, depression and the mechanism of action of antidepressant drugs: a neuroendocrine approach. J Affect Disord 20:1-5
18. Motohashi N (1992) GABA receptor alterations after chronic lithium administration: comparison with carbamazepine and sodium valproate. Prog Neuropsychopharmacol Biol Psychiatry 16:571-579
19. B receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders. Eur J Pharmacol 166:95-99
20. Muller EE (1987) Neural control of somatotropic function. Physiol Rev 67:962-1053
21. O'Flynn K, Dinan TG (1993) Baclofen-induced growth hormone release in major depression: relationship to dexamethasone suppression test result. Am J Psychiatry 150:1728-1730
22. Petty F (1994) Plasma concentrations of γ-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease? Clin Chem 40:296-302
23. Petty F, Kramer GL, Fulton M, Moeller FG, Rush AJ (1993) Low plasma GABA is a trait-like marker for bipolar illness. Neuropsychopharmacology 9:125-132
24. Post RM, Ballenger JC, Hare TA, Goodwin FK, Lake CR, Jimerson DC, Bunnery WE (1980) CSF GABA in normals and patients with affective disorder. Brain Res Bull 5:755-759
25. Shiah I-S, Yatham LN (1998) GABA function in mood disorders: an update and critical review. Life Sci 63:1289-1303
26. Shiah I-S, Yatham LN, Lam RW, Zis AP (1998) Divalproex sodium attenuates growth hormone response to baclofen in healthy human males. Neuropsychopharmacology 18:370-376
27. Spitzer RL, Williams JBW, Gibbon M, First MB (1990) Structured clinical interview for DSM-III-R, patient edition. American Psychiatric Association, Washington, D.C.
28. Spitzer RL, Williams JBW, Gibbon M, First MB (1992) Structured clinical interview for DSM-III-R, nonpatient edition. American Psychiatric Association, Washington, D.C.
29. Thompson PA, Maes M, Meltzer HY (1994) Effects of the placebo control condition in neuroendocrine challenge studies. Psychiatry Res 52:317-326
30. Vance ML, Kaiser FL, Evans WS, Thorner MO, Furlanetto R, Rivier J, Vale W, Perisutti G, Frohman LA (1985) Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man. J Clin Endocrinol Metab 60:370-375
31. Waldmeier PC (1987) Is there a common denominator for the anti-manic effect of lithium and anticonvulsant? Pharmacopsychiatry 20:37-47
32. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 133:429-435